Skip to main content
Clinical Trials/ACTRN12621000674831
ACTRN12621000674831
Recruiting
Phase 4

A multi-centre randomised controlled trial of post-operative doxycycline assessing recovery in patients undergoing endoscopic sinus surgery for the treatment of chronic rhinosinusitis

Dr. Andrew James Wood0 sites50 target enrollmentJune 3, 2021

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Chronic rhinosinusitis
Sponsor
Dr. Andrew James Wood
Enrollment
50
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 3, 2021
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Dr. Andrew James Wood

Eligibility Criteria

Inclusion Criteria

  • Patient undergoing Bilateral Comprehensive Endoscopic Sinus Surgery for the treatment of chronic rhinosinusitis as defined by the European Position Statement, 2020

Exclusion Criteria

  • Prior sinus surgery
  • Predisposing condition (e.g. Aspirin exacerbated respiratory disease, Granulomatosis with Polyangitis, Cystic fibrosis)
  • Antibiotic usage in the 4 weeks prior to recruitment.

Outcomes

Primary Outcomes

Not specified

Similar Trials